Everolimus
These highlights do not include all the information needed to use EVEROLIMUS TABLETS safely and effectively. See full prescribing information for EVEROLIMUS TABLETS. EVEROLIMUS tablets, for oral useInitial U.S. Approval: 2009
5aaf2fb7-93f6-40d6-941a-9583a3794ce7
HUMAN PRESCRIPTION DRUG LABEL
May 13, 2022
Hikma Pharmaceuticals USA Inc.
DUNS: 080189610
Products 4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Everolimus
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (6)
Everolimus
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (6)
Everolimus
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (6)
Everolimus
Product Details
FDA regulatory identification and product classification information